Heart rate

PetPace™ Launches PetPace 2.0, the Only Vet-Grade AI-Powered Canine Pet Collar Providing Continuous Life-Saving Medical Insights for Vets, Researchers and Pet Owners

Retrieved on: 
Monday, March 4, 2024
Professional Services, Consumer Electronics, IOT (Internet of Things), Consumer, Technology, Artificial Intelligence, Health Technology, Data Analytics, Veterinary, Wearables, Mobile Technology, Health, Pets, CVA, Pet, Multimedia, Posture, DVM, Quality of life, Pain, Dog, Heart rate, Vital signs, Respiratory rate, Pulse, University, Behavior, GPS, Disease, Machine learning, Research

PetPace ™, a leader in advanced pet health monitoring, announced today the launch of PetPace 2.0, an AI-powered, life-saving smart dog collar delivering continuous, near real-time medical insights for early detection, treatment, monitoring, and GPS tracking for canine health.

Key Points: 
  • PetPace ™, a leader in advanced pet health monitoring, announced today the launch of PetPace 2.0, an AI-powered, life-saving smart dog collar delivering continuous, near real-time medical insights for early detection, treatment, monitoring, and GPS tracking for canine health.
  • PetPace improves the health and quality of life of pets through remote monitoring, to bring peace of mind to pet owners.
  • Only PetPace AI-powered smart dog collar provides immediate health alerts, continuous vital sign monitoring, proprietary wellness scores, and health comparisons based on their exclusive database.
  • “It also enables the veterinarian to remotely assess the pet’s condition using objective and accurate in its natural setting.”

Validic Integrates with Smart Meter Cellular-enabled Connected Health Devices

Retrieved on: 
Monday, February 26, 2024
Technology, IOT (Internet of Things), Health, Security, Health Technology, Medical Devices, Apps, Applications, Hospitals, Networks, Internet, Mobile, Wireless, Blood, Internet of things, Sleep, Heart rate, Inc., Temperature, Ecosystem, Organization, Patient, Smart meter, Patient satisfaction, Mobile phone

This integration brings exclusive cellular-enabled, patient-friendly monitoring devices supplied by Smart Meter, a leading connected health solution supplier to a rapidly growing nationwide network of SmartPartners, to the Validic ecosystem.

Key Points: 
  • This integration brings exclusive cellular-enabled, patient-friendly monitoring devices supplied by Smart Meter, a leading connected health solution supplier to a rapidly growing nationwide network of SmartPartners, to the Validic ecosystem.
  • "Our proprietary monitoring devices can only connect and transmit patient-generated data when connected to our private data network, ensuring reliable and secure delivery to Validic clients," said Smart Meter Chief Marketing Officer Bill Bassett.
  • Validic's health IoT platform is the largest ecosystem of connected health devices and apps, which streams continuous, near-real-time personal health data from 540+ home health and wearable devices.
  • "The addition of Smart Meter cellular-enabled health monitoring devices to our ecosystem offers another option to help people focus on their health and live their best lives."

FineHeart Widens International IP Protection for FlowMaker®

Retrieved on: 
Tuesday, February 20, 2024
Medical Devices, Surgery, Hospitals, Patent Law, Health Technology, Professional Services, Cardiology, Other Health, Biotechnology, Health, Heart rate, Artificial cardiac pacemaker, Multimedia, Patent, Patient, Medical device

FineHeart S.A., a clinical stage medical device company developing innovative devices for cardiology today announced the successful filing of six new international patents for its FlowMaker®, a fully implantable device for the treatment of patients with advanced heart failure.

Key Points: 
  • FineHeart S.A., a clinical stage medical device company developing innovative devices for cardiology today announced the successful filing of six new international patents for its FlowMaker®, a fully implantable device for the treatment of patients with advanced heart failure.
  • 3 new U.S. patents, a 3rd headline patent in China, 2 patents in India and in Japan strengthen FineHeart's international reputation, particularly in the Asian markets which are highly protective and difficult to access in terms of intellectual and industrial protection.
  • We are also very proud of our patent in Japan, where the excellence of our technology is recognised in a fast moving medical device market.
  • The technological innovations of the FlowMaker® underline our ongoing commitment to improving cardiac care for all patients worldwide."

FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight

Retrieved on: 
Friday, March 8, 2024
Gastroesophageal reflux disease, Research, Heartburn, Blood, Diet, Cholesterol, Dietary supplement, Obesity, Dizziness, Pancreatitis, Vomiting, Health care, History, Thyroid cancer, Fatigue, Hypoglycemia, Acute kidney injury, Depression, Patient, Kidney disease, Abdominal distension, Burping, Cosmetics, Cardiovascular disease, Suicide, Weight, Stroke, Nausea, Diabetic retinopathy, Pancreas, Insulin, Blood pressure, Multimedia, Overweight, Diarrhea, Novo Nordisk, Vaccine, Safety, Heated tobacco product, Indigestion, Heart, Human services, Priority review, Division, Headache, Inflammation, FDA, Food, Weight loss, Thought, Heart rate, Gallstone, Risk, Animal, Allergy, Constipation, Death, Flatulence, Public

"This patient population has a higher risk of cardiovascular death, heart attack and stroke.

Key Points: 
  • "This patient population has a higher risk of cardiovascular death, heart attack and stroke.
  • Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health."
  • Obesity or overweight affect approximately 70% of American adults.
  • Obesity and overweight are serious health issues that increase the risk for premature death and a variety of health problems, including heart attack and stroke.

Inequalities in the face of cardiovascular risk: women the No. 1 victims

Retrieved on: 
Thursday, March 7, 2024
Blood pressure, Breast cancer, Hospital, Woman, Body composition, Cardiovascular disease, Female, Heart rate, Infarction, Chronic pain, Fibrillation, Nausea, Stroke, ECG, Facial muscles, Pregnancy, System, Physiology, Death, Myocardial infarction, Weakness, Risk, Heart failure, Hypertension, Health, Menopause, Biomarker, Fatigue, Withings, Artery, Periodic breathing, Diagnosis, Kidney, Male, Mortality, Ageing, Epidemiology, Pressure, Brain, Pharmaceutical industry

BOSTON, March 7, 2024 /PRNewswire/ -- Cardiovascular disease kills one women every 33 seconds in the USA10. Yet 80% of these deaths could be avoided11 through early diagnosis and awareness of symptoms and risk factors specific to women. To help reduce this excess mortality, Withings is committed to raising awareness via an exclusive survey, and providing the means to tackle their main cause: hypertension, which accounts for the majority of cardiovascular deaths.12

Key Points: 
  • Inequalities also affect health, particularly cardiovascular health: they lead to under-diagnosis and poorer care for women, resulting in avoidable excess mortality.
  • Yet 80% of these deaths could be avoided11 through early diagnosis and awareness of symptoms and risk factors specific to women.
  • Yet 50% of women are unaware of their cardiovascular risk.13
    45.9% of American women surveyed by Withings admit to putting their loved ones' health before their own.
  • Withings and cardiovascular monitoring in women: the need for a real-life, longitudinal approach
    Monitoring cardiovascular health and hypertension involves tracking a range of biomarkers.

Study Illustrates Zeropollution's Enhancing Skin's Resilience to Environmental Damage

Retrieved on: 
Tuesday, March 5, 2024
Quercetin, Lippia, Air pollution, Woman, Capsule, Elasticity, Doctor of Philosophy, Oleuropein, Rosmarinus, Aryl hydrocarbon receptor, Inflammation, Free-radical theory of aging, Pollution, HPLC, Heart rate, Skin, Volunteering, Molecular biology, Radiation, Health, Lipid peroxidation, Caturla, Hesham Tillawi, Sophora, Drink, Reactive oxygen species, Journal, Clinical trial, Oxidative stress, ROS, Endothelium, Tissue, Núria, Antioxidant, DNA, Beauty, Dietary supplement

MADRID, March 5, 2024 /PRNewswire/ -- A new, preclinical study highlights the abilities of a beauty-from-within botanical-blend Zeropollution® to shield skin from the adverse effects of city pollution, especially from free radical damage on a cellular level.

Key Points: 
  • This patented multi-herbal cosmeceutical has been crafted to synergistically strengthen the skin's protective barrier against environmental insults through an "inside out" approach.
  • The study led by Laurent Peno-Mazzarino was published in the Journal of Current Issues in Molecular Biology in January 2024.
  • This encompasses reactive molecules generated by factors such as UV radiation, pollution, and other environmental stressors that can damage cells and tissues.
  • In this study, Zeropollution successfully counteracted the adverse effects of urban dust on the heart rate of zebra fish embryos.

Tampa General Hospital Brings New Hope for Patients with Advanced Blood Cancers

Retrieved on: 
Monday, March 4, 2024
Bone marrow, Blood pressure, Liver, Multiple myeloma, EVP, B-cell lymphoma, Immunotherapy, NHL, Borrello, Temperature, FDA, Physician, Food, Cancer, Hospital, Heart rate, Tampa General Hospital, Cell, Skin, Cancer Institute, B cell, BMT, Ear, Breast, Home, Safety, Bacteria, Johns Hopkins, APRN, Virus, TGH, Leukemia, Non-Hodgkin lymphoma, Patient, Lymphoma, Protein, Tampa, Florida, Medicine, Otorhinolaryngology, Nose, DLBCL, Immune system, Pharmaceutical industry

TAMPA, Fla., March 4, 2024 /PRNewswire/ -- As part of its commitment to harness innovative advances in cancer care, the Tampa General Hospital (TGH) Cancer Institute has added a novel approach to its therapeutic armamentarium for the treatment of patients with aggressive forms of B-cell non-Hodgkin lymphomas and other types of blood cancers.

Key Points: 
  • The field of immunotherapy has evolved from an academic research program to an essential pillar in the treatment of many cancers.
  • All are intended for the treatment of blood cancers, including lymphomas, some forms of leukemia and, most recently, multiple myeloma.
  • Following comprehensive planning and discussion, Tampa General's Hospital at Home program has started to be applied to CAR T patients meeting certain criteria.
  • Due the benefit of remote monitoring, the TGH Cancer Institute and Hospital at Home teams have been working on adapting Hospital at Home for oncology patients.

Senior Living Communities Use Technology to Provide High Level of Care, Reassurance to Family Members

Retrieved on: 
Monday, March 4, 2024
Taproot, Caregiver, Alzheimer's disease, Care, Quality of life, Growth, Heart rate, Health information management, Health, EHR, Emar, Patient, Family, ALIS, Dementia, Residential care

SCOTTSDALE, Ariz., March 4, 2024 /PRNewswire-PRWeb/ -- Technology for senior care has expanded beyond the well known "I've fallen and I can't get up!" Life Alert button, with the global market expected to reach $914 billion by 2025. Within this growth are new devices that track sleep patterns, heart rate and daily activity, keeping families of independent and assisted living residents up-to-date on the health of their loved ones. Solterra Companies has implemented this technology in order to provide more independence and higher quality of life. Their high tech nurse call system, Care Predict, is wireless and also tracks residents' daily health stats. Care Predict notices small changes in seniors and can alert loved ones of serious health issues, before they even happen.

Key Points: 
  • Solterra Companies has implemented this technology in order to provide more independence and higher quality of life.
  • With a comprehensive suite of eHR tools, ALIS software solves the important challenges assisted living communities face using fast, secure technology.
  • Solterra Senior Living and BridgeWater Assisted Living communities strive to provide compassionate care in a comfortable and respectful manner.
  • With a comprehensive suite of eHR tools, ALIS software solves the important challenges assisted living communities face using fast and secure technology.

Babylon Dental Care welcomes Dr. Maximilian Marks to the practice

Retrieved on: 
Tuesday, February 27, 2024
Binghamton University, Pain, Heart rate, Dental care, Dentist, NYU, Dentistry, Jamaica Hospital Medical Center, Crow, Patient, Family, Giant, Child, Research

WEST BABYLON, N.Y., Feb. 27, 2024 /PRNewswire/ -- Babylon Dental Care is excited to announce the latest addition to our family, Dr. Maximilian Marks!

Key Points: 
  • WEST BABYLON, N.Y., Feb. 27, 2024 /PRNewswire/ -- Babylon Dental Care is excited to announce the latest addition to our family, Dr. Maximilian Marks!
  • Dr. Marks is a second-generation dentist whose father has been practicing for 50 years, a connection that gave him an up-close look at the importance of high-quality, patient-focused dental care.
  • Dr. Marks is excited to bring this cutting-edge technique for pain reduction with him to Babylon Dental Care.
  • This goal makes him a good fit for Babylon Dental Care.

Aktiia Secures CHF 27 Million (USD 30M) in Funding from Khosla Ventures and Others, Welcomes Daniel Graf as New President and Board Member to Accelerate Innovation in Hypertension Management

Retrieved on: 
Tuesday, February 27, 2024
Blood pressure, USD, Entrepreneurship, Uber, Heart rate, Daniel, CHF, Verve, Death, Data, Khosla Ventures, Hypertension, Health, Deep learning, Research, Pharmaceutical industry

In conjunction with this funding, Aktiia is delighted to welcome Daniel Graf as its new President and Board Member.

Key Points: 
  • In conjunction with this funding, Aktiia is delighted to welcome Daniel Graf as its new President and Board Member.
  • Daniel, a seasoned technology executive with a distinguished career at companies like Uber and Google, brings a wealth of experience in entrepreneurship, product innovation, and scaling businesses.
  • His leadership will be instrumental in guiding Aktiia's strategic direction and expansion as the company continues to pioneer advancements in hypertension management.
  • "We are proud to have Daniel join our board and executive team," said Mattia Bertschi, CEO of Aktiia.